Cann Group Limited
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CNGGF research report →
About the company
Cann Group Limited specializes in the end-to-end process of bringing medicinal cannabis to market. Its activities span from genetic development and cultivation to product manufacturing, clinical trials, and ultimately, the supply of therapeutic cannabis for both Australian consumption and international export. The company holds specific licenses enabling it to conduct research and grow cannabis for human medicinal and scientific study.
- CEO
- Jennifer Lee Pilcher
- IPO
- 2021
- Employees
- 98
- HQ
- Port Melbourne, VIC, AU
Price Chart
- Market Cap
- $2.40M
- P/E
- 0.26
- P/S
- 0.28
- P/B
- 0.11
- EV/EBITDA
- -2.35
- Div Yield
- 0.00%
- Gross Margin
- -20.82%
- Op Margin
- -97.39%
- Net Margin
- 130.29%
- ROE
- 93.89%
- ROIC
- -22.26%
- Revenue
- $13.25M · -13.79%
- Net Income
- $-22,345,000 · 56.39%
- EPS
- $-0.04 · 61.55%
- Op Income
- $-8,942,000
- FCF YoY
- 44.60%
- 52W High
- $0.03
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.01
- Beta
- 0.14
- Avg Volume
- 306
Get TickerSpark's AI analysis on CNGGF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our CNGGF coverage
Recent articles, reports, and earnings notes.
No research on CNGGF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate CNGGF report →Similar companies
Peers in the same neighborhood.